In 2026, legislative attention on pharmacy benefit manager (PBM) transparency and reimbursement practices continues to grow. Independent pharmacies have long raised concerns about opaque pricing and reimbursement delays that impact financial stability. This year, several proposals in Congress aim to enhance reporting requirements, strengthen oversight, and increase transparency around pricing and clawbacks.
The Pharmacy Benefit Manager Reform Act and related initiatives are attracting bipartisan support and industry input, signaling potential shifts in how PBMs operate within the drug supply chain. For independent pharmacy owners and partners, these developments could bring greater clarity and fairness to reimbursement structures — a critical factor for long-term sustainability.
While nothing has become law yet, committee hearings and stakeholder engagement throughout the first quarter of 2026 suggest that reform efforts are gaining traction.
Read More:
• Congress Passes Landmark PBM Reform Law (Press release) — https://republicans-energycommerce.house.gov/posts/chairman-guthrie-celebrates-long-awaited-pbm-reform-being-signed-into-law
